Prevention of serogroup B meningococcal disease

被引：3
|
作者：
Stephens, David S. [1 ,2 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[2] VA Med Ctr, Atlanta, GA 30033 USA
来源：
LANCET | 2012年 / 379卷 / 9816期
关键词：
VACCINES; EPIDEMIC;
D O I：
10.1016/S0140-6736(11)61934-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：592 / 594
页数：4
相关论文
共 50 条
  • [21] MENINGOCOCCAL SEROTYPES AND SEROGROUP-B DISEASE IN NORTHWEST EUROPE
    FALLON, RJ
    [J]. LANCET, 1986, 2 (8510): : 807 - 808
  • [22] SERUM OPSONINS TO SEROGROUP-B MENINGOCOCCI IN MENINGOCOCCAL DISEASE
    HALSTENSEN, A
    SJURSEN, H
    VOLLSET, SE
    FROHOLM, LO
    NAESS, A
    MATRE, R
    SOLBERG, CO
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1989, 21 (03) : 267 - 276
  • [23] Pros and cons of vaccination against serogroup B meningococcal disease
    Delgado Rodriguez, Miguel
    Dominguez Garcia, Angela
    [J]. MEDICINA CLINICA, 2018, 150 (03): : 109 - 113
  • [24] Outbreak of Serogroup B Meningococcal Disease at a University - California, 2016
    Biswas, Hope H.
    Han, George S.
    Wendorf, Kristen
    Winter, Kathleen
    Zipprich, Jennifer
    Perti, Tara
    Martinez, Linda
    Arellano, Aileen
    Kyle, Jennifer L.
    Zhang, Peng
    Harriman, Kathleen
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (20): : 520 - 521
  • [25] Serogroup B meningococcal disease - New outbreaks, new strategies
    Wenger, JD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (16): : 1541 - 1543
  • [26] Controlling serogroup B invasive meningococcal disease: the Canadian perspective
    Bettinger, Julie A.
    Deeks, Shelley L.
    Halperin, Scott A.
    Tsang, Raymond
    Scheifele, David W.
    [J]. EXPERT REVIEW OF VACCINES, 2013, 12 (05) : 505 - 517
  • [27] MENINGOCOCCAL SEROTYPES AND SEROGROUP-B DISEASE IN NORTHWEST EUROPE
    POOLMAN, JT
    JONSDOTTIR, K
    JONES, DM
    LIND, I
    FROHOLM, LO
    ZANEN, HC
    [J]. LANCET, 1986, 2 (8506): : 555 - 558
  • [28] A cluster of invasive meningococcal disease revealed by the characterization of a novel serogroup B meningococcal clone
    Valinsky, L.
    Jaffe, J.
    Keller, N.
    Block, C.
    Abramson, N.
    Stein-Zamir, C.
    [J]. EPIDEMIOLOGY AND INFECTION, 2016, 144 (01): : 183 - 188
  • [29] Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease
    Watson, Philip S.
    Turner, David P. J.
    [J]. VACCINE, 2016, 34 (07) : 875 - 880
  • [30] SEROGROUP-B MENINGOCOCCAL INFECTION
    POKROVSKY, VI
    DEMINA, AA
    [J]. ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1987, (05): : 36 - 40
12345